Targeting the CAF–LPL–STAT3 axis mitigates osimertinib resistance associated with EGFR downregulation
Cellular Signalling
· Elsevier
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Читать у издателя →
Цитирование
Targeting the CAF–LPL–STAT3 axis mitigates osimertinib resistance associated with EGFR downregulation. // Cellular Signalling. – URL: https://www.sciencedirect.com/science/article/pii/S089865682600570X?dgcid=rss_sd_all
Targeting the CAF–LPL–STAT3 axis mitigates osimertinib resistance associated with EGFR downregulation. Cellular Signalling. https://www.sciencedirect.com/science/article/pii/S089865682600570X?dgcid=rss_sd_all
“Targeting the CAF–LPL–STAT3 axis mitigates osimertinib resistance associated with EGFR downregulation.” Cellular Signalling.
@article{article118447,
title = {Targeting the CAF–LPL–STAT3 axis mitigates osimertinib resistance associated with EGFR downregulation},
journal = {Cellular Signalling},
url = {https://www.sciencedirect.com/science/article/pii/S089865682600570X?dgcid=rss_sd_all}
}